0001127602-22-019006.txt : 20220706
0001127602-22-019006.hdr.sgml : 20220706
20220706181749
ACCESSION NUMBER: 0001127602-22-019006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220701
FILED AS OF DATE: 20220706
DATE AS OF CHANGE: 20220706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hykes Andrew
CENTRAL INDEX KEY: 0001806431
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 221070064
MAIL ADDRESS:
STREET 1: C/O INARI MEDICAL, INC.
STREET 2: 9 PARKER AVENUE, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-07-01
0001531048
Inari Medical, Inc.
NARI
0001806431
Hykes Andrew
C/O INARI MEDICAL, INC.
6001 OAK CANYON
IRVINE
CA
92618
1
Chief Operating Officer
Common Stock
2022-07-01
4
F
0
347
68.66
D
146637
D
Common Stock
2022-07-01
4
F
0
646
68.66
D
145991
D
Common Stock
2022-07-05
4
S
0
5000
70.31
D
140991
D
Common Stock
1550
I
By Child 1
Common Stock
1550
I
By Child 2
Common Stock
1550
I
By Child 3
Common Stock
1000
I
By Spouse
Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021.
Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2021.
This transaction was executed in multiple trades at prices ranging from $70.00 to $70.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
2022-07-06